ICD   PCS   Disclaimer
PCS-2023 Procedure Codes Overview
PCS-2023 > 3 > 3E > 3E0 > 3E0M
3E0

Physiological Systems and Anatomical Regions, Introduction

Info:
Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
3E0M

Introduction, Peritoneal Cavity

3E0M0
Open
3E0M05
Adhesion Barrier
3E0M05Z
Introduction of Adhesion Barrier into Peritoneal Cavity, Open Approach
3E0M3
Percutaneous
3E0M30
Antineoplastic
3E0M304
Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Percutaneous Approach
3E0M305
Introduction of Other Antineoplastic into Peritoneal Cavity, Percutaneous Approach
3E0M30M
Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Percutaneous Approach
3E0M30Y
Introduction of Hyperthermic Antineoplastic into Peritoneal Cavity, Percutaneous Approach
3E0M32
Anti-infective
3E0M328
Introduction of Oxazolidinones into Peritoneal Cavity, Percutaneous Approach
3E0M329
Introduction of Other Anti-infective into Peritoneal Cavity, Percutaneous Approach
3E0M33
Anti-inflammatory
3E0M33Z
Introduction of Anti-inflammatory into Peritoneal Cavity, Percutaneous Approach
3E0M35
Adhesion Barrier
3E0M35Z
Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Approach
3E0M36
Nutritional Substance
3E0M36Z
Introduction of Nutritional Substance into Peritoneal Cavity, Percutaneous Approach
3E0M37
Electrolytic and Water Balance Substance
3E0M37Z
Introduction of Electrolytic and Water Balance Substance into Peritoneal Cavity, Percutaneous Approach
3E0M3B
Anesthetic Agent
3E0M3BZ
Introduction of Anesthetic Agent into Peritoneal Cavity, Percutaneous Approach
3E0M3H
Radioactive Substance
3E0M3HZ
Introduction of Radioactive Substance into Peritoneal Cavity, Percutaneous Approach
3E0M3K
Other Diagnostic Substance
3E0M3KZ
Introduction of Other Diagnostic Substance into Peritoneal Cavity, Percutaneous Approach
3E0M3N
Analgesics, Hypnotics, Sedatives
3E0M3NZ
Introduction of Analgesics, Hypnotics, Sedatives into Peritoneal Cavity, Percutaneous Approach
3E0M3T
Destructive Agent
3E0M3TZ
Introduction of Destructive Agent into Peritoneal Cavity, Percutaneous Approach
3E0M3G
Other Therapeutic Substance
3E0M3GC
Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Approach
3E0M3S
Gas
3E0M3SF
Introduction of Other Gas into Peritoneal Cavity, Percutaneous Approach
3E0M4
Percutaneous Endoscopic
3E0M45
Adhesion Barrier
3E0M45Z
Introduction of Adhesion Barrier into Peritoneal Cavity, Percutaneous Endoscopic Approach
3E0M4G
Other Therapeutic Substance
3E0M4GC
Introduction of Other Therapeutic Substance into Peritoneal Cavity, Percutaneous Endoscopic Approach
3E0M7
Via Natural or Artificial Opening
3E0M70
Antineoplastic
3E0M704
Introduction of Liquid Brachytherapy Radioisotope into Peritoneal Cavity, Via Natural or Artificial Opening
3E0M705
Introduction of Other Antineoplastic into Peritoneal Cavity, Via Natural or Artificial Opening
3E0M70M
Introduction of Antineoplastic, Monoclonal Antibody, into Peritoneal Cavity, Via Natural or Artificial Opening
3E0M7S
Gas
3E0M7SF
Introduction of Other Gas into Peritoneal Cavity, Via Natural or Artificial Opening

 

ICD-10-CM-2023 Code Search Engine and PCS-2023 Code Search Engine